Physician profile
Ivan Pinon
NPI 1902990393
$4,838.46
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,724 · 2020: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $2,322.05 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $1,495.70 | 2019 | |
| Amgen INC. | $219.25 | 2019-2020 | |
| Novo Nordisk INC | $201.55 | 2019-2020 | |
| Lilly USA, LLC | $151.14 | 2019-2020 | |
| Dexcom, INC. | $138.42 | 2019 | |
| Janssen Biotech, INC. | $70.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.33 | 2019-2020 | |
| Abbvie INC. | $26.32 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $25.78 | 2019 | |
| Insulet Corporation | $23.01 | 2019 | |
| Becton, Dickinson and Company | $20.06 | 2019 | |
| Abbott Laboratories | $17.26 | 2019 | |
| Radius Health, INC. | $16.06 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Pinon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.